Gene · 4041
Papers4,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 4,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Acupuncture May Be a Potential Complementary Therapy for Alzheimer's Disease: A Network Meta-Analysis. | Evid Based Complement Alternat Med | 2022 | 36467555 | PubTator, text mining | PubMed |
| Genetic epidemiology of inherited retinal diseases in a large patient cohort followed at a single center in Italy. | Sci Rep | 2022 | 36460718 | PubTator, text mining | PubMed |
| Identifying novel interactions of the colon-cancer related APC protein with Wnt-pathway nuclear transcription factors. | Cancer Cell Int | 2022 | 36457029 | PubTator, text mining | PubMed |
| Amino acid transporter SLC38A5 regulates developmental and pathological retinal angiogenesis. | Elife | 2022 | 36454214 | PubTator, text mining | PubMed |
| Unveiling the transcriptomic landscape and the potential antagonist feedback mechanisms of TGF-β superfamily signaling module in bone and osteoporosis. | Cell Commun Signal | 2022 | 36443839 | PubTator, text mining | PubMed |
| Effectiveness and safety of herbal medicine Ukgansan for clinical symptoms in Parkinson's disease: A pilot, randomized, assessor-blinded clinical trial. | Front Neurol | 2022 | 36438946 | PubTator, text mining | PubMed |
| The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases. | Theranostics | 2022 | 36438498 | PubTator, text mining | PubMed |
| Association between OPG polymorphisms and osteoporosis risk: An updated meta-analysis. | Front Genet | 2022 | 36437941 | PubTator, text mining | PubMed |
| Selective Activation of the Wnt-Signaling Pathway as a Novel Therapy for the Treatment of Diabetic Retinopathy and Other Retinal Vascular Diseases. | Pharmaceutics | 2022 | 36432666 | PubTator, text mining | PubMed |
| Crosstalk between the Hippo Pathway and the Wnt Pathway in Huntington's Disease and Other Neurodegenerative Disorders. | Cells | 2022 | 36429058 | PubTator, text mining | PubMed |
| Effectiveness of Acupuncture in Parkinson's Disease Symptoms-A Systematic Review. | Healthcare (Basel) | 2022 | 36421658 | PubTator, text mining | PubMed |
| Clinical characteristics and mutation spectrum in 33 Chinese families with familial exudative vitreoretinopathy. | Ann Med | 2022 | 36411543 | PubTator, text mining | PubMed |
| Current state of research on acupuncture for the treatment of amyotrophic lateral sclerosis: A scoping review. | Front Neurol | 2022 | 36408510 | PubTator, text mining | PubMed |
| An Overview of Systematic Reviews: Acupuncture in the Treatment of Essential Hypertension. | Int J Gen Med | 2022 | 36389015 | PubTator, text mining | PubMed |
| Effect of intradermal needle therapy at combined acupoints on patients' gastrointestinal function following surgery for gastrointestinal tumors. | World J Clin Cases | 2022 | 36387814 | PubTator, text mining | PubMed |
| Polydatin administration attenuates the severe sublesional bone loss in mice with chronic spinal cord injury. | Aging (Albany NY) | 2022 | 36378815 | PubTator, text mining | PubMed |
| Fulminant lung fibrosis in non-resolvable COVID-19 requiring transplantation. | EBioMedicine | 2022 | 36375315 | PubTator, text mining | PubMed |
| Metabolic Bone Diseases-A Topic of Great Diversity. | J Clin Med | 2022 | 36362675 | PubTator, text mining | PubMed |
| Signal Peptide Variants in Inherited Retinal Diseases: A Multi-Institutional Case Series. | Int J Mol Sci | 2022 | 36362148 | PubTator, text mining | PubMed |
| Genome-Wide Detection of Selection Signatures for Pelt Quality Traits and Coat Color Using Whole-Genome Sequencing Data in American Mink. | Genes (Basel) | 2022 | 36360176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4041/papers?page=32